from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2646/-

LFCtreatmentdescriptionclass of inhibitor

0.263

Amikacinug/mL Amikacintranslation

1.059

Cap5-10ug/mL Capreomycintranslation

0.193

Rox10-50 ug/mL Roxithromycintranslation

0.000

SM2-5 ug/mL Streptomycintranslation

0.467

Tet5-10 ug/mL Tetracyclinetranslation

0.378

Rif0.2-5ug/mL Rifampicintranscription

0.170

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.001

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.124

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.641

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.276

Clofazimine10-13 ug/mL Clofaziminerespiration

0.120

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.341

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.411

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.165

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.203

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.067

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.697

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.485

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.093

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-1.060

Nigericin50 uM Nigericinrespiration

-0.313

TRC10-150 ug/mL Triclosanrespiration

-0.316

TRZ10-25 ug/mL Thioridazinerespiration

0.356

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.311

menadione6-10 ug/mL Menadionerespiration

-0.568

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.271

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.023

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.016

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.164

NRP_1Non-replicating persistence stage 1dosRassociated

-0.403

Amp0.2mg/mL AmpicillincellWall

-0.340

Cephalexin20-100 ug/mL CephalexincellWall

-0.186

Cerulenin0.32-5 ug/mL CerulenincellWall

0.885

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.559

EMB10-20 ug/mL EthambutolcellWall

1.103

Eta12-40 ug/mL EthionamidecellWall

-0.441

INH0.2-0.4 ug/mL IsoniazidcellWall

0.007

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.903

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.124

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.253

BZA0.12 mg/mL BenzamidearomaticAmides

0.800

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.341

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

1.101

H2O24 mM hydrogen peroxideDNAdamaging

-0.098

Levo10 ug/mL LevofloxacinDNAdamaging

0.853

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.102

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.817

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.871

UVUV-irradiationDNAdamaging

-1.800

ARP41-4 ug/mL Antitubercular compound ARP4?

-1.346

Antimycin12.5-50 ug/mL Antimycin A?

-1.409

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.657

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.048

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.229

PA8240.2-2 ug/mL PA-824?

-0.716

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.378

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-1.529

Verapamil50 uM Verapamil?

-1.387

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.143

methoxatin10-20 ug/mL Methoxatin?